miR-200c/141 Regulates Breast Cancer Stem Cell Heterogeneity via Targeting HIPK1/β-Catenin Axis

Bingjie Liu(Fudan University Shanghai Cancer Center), Suling Liu(Shanghai Medical College of Fudan University)
Theranostics
January 1, 2018
Cited by 65


Related Papers